Metabolically healthy obesity has been associated with lower circulating OPG concentrations, possibly representing a counteracting mechanism, while elevated serum OPG levels may reflect an increased risk of metabolic dysfunction or cardiovascular disease. This evidence concerns the gene TNFRSF11B and obesity due to melanocortin 4 receptor deficiency.